Article
Impact of Lineage Plasticity to and from a Neuroendocrine Phenotype on Progression and Response in Prostate and Lung Cancers.
Molecular cell - 19 Nov 2020
Rubin Mark A, Bristow Robert G, Thienger Phillip D, Dive Caroline, Imielinski Marcin
Abstract excerpt
Intratumoral heterogeneity can occur via phenotype transitions, often after chronic exposure to targeted anticancer agents. This process, termed lineage plasticity, is associated with acquired independence to an initial oncogenic driver, resulting in treatment failure. In non-small cell lung cancer (NSCLC) and prostate cancers, lineage plasticity manifests when the adenocarcinoma phenotype transforms into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
